Order Total (1 Item Items):
Shipping Destination:
Mitchell Cairo (40 results)
Skip to main search results
Search filters
Product Type
- All Product Types
- Books (40)
- Magazines & Periodicals (No further results match this refinement)
- Comics (No further results match this refinement)
- Sheet Music (No further results match this refinement)
- Art, Prints & Posters (No further results match this refinement)
- Photographs (No further results match this refinement)
- Maps (No further results match this refinement)
- Manuscripts & Paper Collectibles (No further results match this refinement)
Condition Learn more
Binding
Collectible Attributes
- First Edition (1)
- Signed (No further results match this refinement)
- Dust Jacket (No further results match this refinement)
- Seller-Supplied Images (10)
- Not Print on Demand (28)
Language (1)
Free Shipping
Seller Location
Seller Rating
-
Paperback. Condition: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority!
-
Paperback. Condition: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
-
Paperback. Condition: Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.
-
Pediatric Hematology/Oncology Secrets
Book 4 of 66: SecretsLanguage: English
Published by Elsevier - Health Sciences Division, 2001
ISBN 10: 1560534443 ISBN 13: 9781560534440
First Edition
Condition: Very Good. 1st Edition. Pages intact with possible writing/highlighting. Binding strong with minor wear. Dust jackets/supplements may not be included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
-
Pediatric Hematology/Oncology Secrets
Book 4 of 66: SecretsSeller: Goodwill of Silicon Valley, SAN JOSE, CA, U.S.A.
Seller rating 5 out of 5 stars
Condition: acceptable. Supports Goodwill of Silicon Valley job training programs. The cover and pages are in Acceptable condition! Any other included accessories are also in Acceptable condition showing use. Use can include some highlighting and writing, page and cover creases as well as other types visible wear such as cover tears discoloration, staining, marks, scuffs, etc. All pages intact.
-
US$ 23.83
US$ 16.31 shipping
Ships from United Kingdom to U.S.A.Quantity: 1 available
Add to basketpaperback. Condition: Good. Our good condition books are generally good for reading but not for gifting or collecting. They could have imperfections such as creasing, fanning, inscriptions, margin notes, yellowing, staining on edge or cover or pages, bumps, scuffs, etc etc (sometimes multiple of these). It's a wide category that encompasses anything that isn't almost-new down to anything that is slightly better than poor. We would NOT recommend gifting Good books - these should be considered reading copies. Our books are dispatched from a Yorkshire former cotton mill. We list via barcode/ISBN so please note that the images are stock images and may not be the exact copy you receive, furthermore the details about edition and year might not be accurate as many publishers reuse the same ISBN for multiple editions and as we simply scan a barcode or enter an ISBN we do not check the validity of the edition data when listing. If you're looking for an exact edition please don't order (at least not without checking with us first, although we don't always have time to check). We aim to dispatch prompty, the service used will depend on order value and book size. We can ship to most countries, see our shipping policies. Payment is via Abe only.
-
HEMATOLOGICAL MALIGNANCIES IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS (WITH CD-ROM)
Language: English
Published by World Scientific Publishing Comp, 2012
ISBN 10: 981429960X ISBN 13: 9789814299602
bundle. Condition: Very Good. Fast Shipping - Safe and Secure 7 days a week!
-
Condition: New. Satisfaction Guaranteed or your money back.
-
Resistance to Targeted Therapies in Lymphomas (Resistance to Targeted Anti-Cancer Therapeutics)
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
US$ 133.99
US$ 16.09 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. In.
-
Resistance to Targeted Therapies in Lymphomas (Resistance to Targeted Anti-Cancer Therapeutics, 21)
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
US$ 133.99
US$ 16.09 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. In.
-
US$ 131.01
US$ 20.80 shipping
Ships from United Kingdom to U.S.A.Quantity: 10 available
Add to basketPF. Condition: New.
-
Resistance To Targeted Therapies In Lymp
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Seller rating 5 out of 5 stars
Condition: New.
-
Condition: New. pp. XX, 210 27 illus., 26 illus. in color. 1st ed. 2019 edition NO-PA16APR2015-KAP.
-
-
US$ 177.95
US$ 13.43 shipping
Ships from United Kingdom to U.S.A.Quantity: 2 available
Add to basketHardcover. Condition: Brand New. har/psc edition. 232 pages. 9.25x6.10x0.75 inches. In Stock.
-
Taschenbuch. Condition: Neu. Resistance to Targeted Therapies in Lymphomas | Ana C. Xavier (u. a.) | Taschenbuch | Resistance to Targeted Anti-Cancer Therapeutics | xx | Englisch | 2020 | Springer | EAN 9783030244262 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
-
Condition: New.
-
Resistance to Targeted Therapies in Lymphomas
Language: English
Published by Springer International Publishing, 2020
ISBN 10: 3030244261 ISBN 13: 9783030244262
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Over the past few decades, lymphoma patient outcomes have improved as a result of multidrug chemotherapy and radiation therapy, intensification of treatment, improvement in supportive care, and better imaging and staging systems. Even more recently, there has been tremendous progress in the understanding of cancer cell biology and its microenvironment which has resulted in the development of biologic agents, also called 'target' therapies. These therapies are more specific in targeting cancer cells either directly or via enhancement of the immune system. Many clinical studies have focused on biological agents in combination with traditional chemotherapy with the goal of improved outcomes, or reduced acute long term complications that are associated with lymphoma therapy.This volume will review different classes of 'target' drugs that have been developed, approved, or are under investigation in the field of lymphoma therapy. The discussion will not only be on the understanding of the mechanisms of action or clinical response of those agents, but will also help the reader to understand the nature of lymphoma biology in patients who relapse or are refractor after exposure to those drugs.Contributors will discuss what is currently known about mechanisms of tumor-related or host-related resistance, and how to overcome this resistance. This understanding is crucial given the dismal outcomes of patients with relapsed or refractory lymphomas. The book provides a unique opportunity to review and reflect on the recent successes and pitfalls of the modern lymphoma therapy era.
-
Resistance to Targeted Therapies in Lymphomas
Language: English
Published by Springer International Publishing, 2019
ISBN 10: 3030244237 ISBN 13: 9783030244231
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Over the past few decades, lymphoma patient outcomes have improved as a result of multidrug chemotherapy and radiation therapy, intensification of treatment, improvement in supportive care, and better imaging and staging systems. Even more recently, there has been tremendous progress in the understanding of cancer cell biology and its microenvironment which has resulted in the development of biologic agents, also called 'target' therapies. These therapies are more specific in targeting cancer cells either directly or via enhancement of the immune system. Many clinical studies have focused on biological agents in combination with traditional chemotherapy with the goal of improved outcomes, or reduced acute long term complications that are associated with lymphoma therapy.This volume will review different classes of 'target' drugs that have been developed, approved, or are under investigation in the field of lymphoma therapy. The discussion will not only be on the understanding of the mechanisms of action or clinical response of those agents, but will also help the reader to understand the nature of lymphoma biology in patients who relapse or are refractor after exposure to those drugs.Contributors will discuss what is currently known about mechanisms of tumor-related or host-related resistance, and how to overcome this resistance. This understanding is crucial given the dismal outcomes of patients with relapsed or refractory lymphomas. The book provides a unique opportunity to review and reflect on the recent successes and pitfalls of the modern lymphoma therapy era.
-
Condition: Hervorragend. Zustand: Hervorragend | Sprache: Englisch | Produktart: Bücher | Over the past few decades, lymphoma patient outcomes have improved as a result of multidrug chemotherapy and radiation therapy, intensification of treatment, improvement in supportive care, and better imaging and staging systems. Even more recently, there has been tremendous progress in the understanding of cancer cell biology and its microenvironment which has resulted in the development of biologic agents, also called "target" therapies. These therapies are more specific in targeting cancer cells either directly or via enhancement of the immune system. Many clinical studies have focused on biological agents in combination with traditional chemotherapy with the goal of improved outcomes, or reduced acute long term complications that are associated with lymphoma therapy. This volume will review different classes of "target" drugs that have been developed, approved, or are under investigation in the field of lymphoma therapy. The discussion will not only be on the understanding of the mechanisms of action or clinical response of those agents, but will also help the reader to understand the nature of lymphoma biology in patients who relapse or are refractor after exposure to those drugs. Contributors will discuss what is currently known about mechanisms of tumor-related or host-related resistance, and how to overcome this resistance. This understanding is crucial given the dismal outcomes of patients with relapsed or refractory lymphomas. The book provides a unique opportunity to review and reflect on the recent successes and pitfalls of the modern lymphoma therapy era.
-
US$ 204.69
US$ 33.57 shipping
Ships from United Kingdom to U.S.A.Quantity: 1 available
Add to basketHardcover. Condition: New. New. book.
-
Hematological Malignancies in Children, Adolescents and Young Adults (With CD-ROM)
Language: English
Published by World Scientific Publishing Company, 2012
ISBN 10: 981429960X ISBN 13: 9789814299602
Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
-
Hematological Malignancies in Children, Adolescents and Young Adults (With CD-ROM)
Language: English
Published by World Scientific Publishing Company, 2012
ISBN 10: 981429960X ISBN 13: 9789814299602
Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
-
Hematological Malignancies in Children, Adolescents and Young Adults (With CD-ROM)
Language: English
Published by World Scientific Publishing Company, 2012
ISBN 10: 981429960X ISBN 13: 9789814299602
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
-
Hematological Malignancies in Children, Adolescents, and Young Adults
Language: English
Published by World Scientific Publishing Company, Incorporated, 2012
ISBN 10: 981429960X ISBN 13: 9789814299602
Condition: Used. pp. xix + 580.
-
Hematological Malignancies in Children, Adolescents, and Young Adults
Language: English
Published by World Scientific Publishing Company, Incorporated, 2012
ISBN 10: 981429960X ISBN 13: 9789814299602
US$ 172.79
US$ 8.73 shipping
Ships from United Kingdom to U.S.A.Quantity: 1 available
Add to basketCondition: Used. pp. xix + 580.
-
Hematological Malignancies in Children, Adolescents and Young Adults
Language: English
Published by World Scientific Publishing Company, 2012
ISBN 10: 981429960X ISBN 13: 9789814299602
Condition: Sehr gut. Zustand: Sehr gut | Seiten: 600 | Sprache: Englisch | Produktart: Bücher | Bringing together intellectual and scientific experts from pediatrics, adolescent medicine, general medicine, pathology, biology, nursing and psychology, this book is the first of its kind to cover the topics of leukemias and lymphomas in young patients ranging from infants to young adults. The content is organized and subdivided into four major sections under the main headings of General Considerations, Pathobiology, Clinical Manifestations and Treatment, and Supportive Care and Complications for ease of reference to readers. Hematological Malignancies in Children, Adolescents and Young Adults presents a comprehensive multidisciplinary review of the field of hematological malignancies and brings forth illuminating perspectives from an internationally recognized group of leading authorities in the field.
-
Hematological Malignancies in Children, Adolescents, and Young Adults
Language: English
Published by World Scientific Publishing Company, Incorporated, 2012
ISBN 10: 981429960X ISBN 13: 9789814299602
Condition: Used. pp. xix + 580.
-
Condition: new. Questo è un articolo print on demand.
-
Condition: new. Questo è un articolo print on demand.
